The Past, Present, and Future of Noninvasive Test in Chronic Liver Diseases

Link to article at PubMed

Med Clin North Am. 2023 May;107(3):397-421. doi: 10.1016/j.mcna.2022.12.001. Epub 2023 Feb 20.


Chronic liver disease is a major global health threat and is the 11th leading cause of death globally. A liver biopsy is frequently required in assessing the degree of steatosis and fibrosis, information that is important in diagnosis, management, and prognostication. However, liver biopsies have limitations and carry a considerable risk, leading to the development of various modalities of noninvasive testing tools. These tools have been developed in recent years and have improved markedly in diagnostic accuracy. Moving forward, they may change the practice of hepatology.

PMID:37001944 | DOI:10.1016/j.mcna.2022.12.001

Leave a Reply

Your email address will not be published. Required fields are marked *